Kabra Drugs Ltd. Share Price & Stock Analysis

Kabra Drugs Ltd. (BSE: 524322) is a Chennai, Tamil Nadu-based company in the Pharmaceuticals industry. With a market capitalisation of ₹49 Cr, it ranks #3,811 by market cap among the 6,197 Indian listed companies on FinBizNet, and #51 of 63 in Pharmaceuticals. At ₹20.50 (as of 16 Nov 2026), the share price is 42.3% below its 52-week high of ₹35.52 and 34.4% above its 52-week low of ₹15.25. The share price is up 6.6% over one year and down 14.6% over three months.

Key Metrics

Current Price₹20.50
Market Cap₹49 Cr
BSE Code524322
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryBiotechnology and Life Sciences > Pharmaceuticals
P/E Ratio9.9
Return on Equity18.28%
Return on Assets5.89%
52-Week Range₹15.25 – ₹35.52
1-Year Price Change+6.6%
3-Month Price Change-14.6%
Beta (1Y)0.48
HeadquartersChennai, Tamil Nadu
Websitewww.kabradrugs.com

Latest Quarterly Results — Q1 FY27

Revenue₹46 Cr
Net Profit₹2 Cr
Net Margin4.6%
EPS (Basic)₹0.90
Basisstandalone

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Kabra Drugs Ltd. Quarterly Revenue and Profit Trend

Kabra Drugs Ltd. reported revenue of ₹46 Cr in Q1 FY27, up 546.4% from ₹7 Cr in Q1 FY26 and up 30.5% from ₹35 Cr in Q4 FY26. It posted a net profit of ₹2 Cr for the quarter, against a net loss of ₹1 Cr in Q1 FY26. Across the 8 quarters from Q2 FY25 to Q1 FY27, quarterly revenue ranged from ₹0 Cr (Q4 FY25) to ₹46 Cr (Q1 FY27). The company reported a net loss in 3 of these 8 quarters.

QuarterRevenueNet ProfitNet Margin
Q1 FY27₹46 Cr₹2 Cr4.6%
Q4 FY26₹35 Cr₹1 Cr3.0%
Q3 FY26₹30 Cr₹3 Cr8.4%
Q2 FY26₹20 Cr₹2 Cr9.3%
Q1 FY26₹7 Cr−₹1 Cr−7.0%
Q4 FY25₹0 Cr₹0 Cr—
Q3 FY25₹0 Cr−₹1 Cr—
Q2 FY25₹0 Cr−₹0 Cr—

Standalone figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 60.49% of Kabra Drugs Ltd.'s shares as of Mar 2026, against 60.24% in Mar 2025 (+0.25 percentage points). Delivery averaged 75.8% of traded volume across 15 BSE sessions (21 Oct 2026 – 13 Nov 2026).

About Kabra Drugs Ltd.

Kabra Drugs Limited does not have significant operations. Previously, the company was engaged in permaculture manufacturing and trading of pharma related products. Kabra Drugs Limited was incorporated in 1989 and is based in Chennai, India.

Products and Services

1. Pharmaceuticals-This segment engages in the manufacture and sale of drugs in India. It offers ether, derivative, and pharmaceutical formulations. It manufactures ether derivatives, which include diethyl and solvent ethers, ethyl chloride sprays, and surgical products; liquid and dry injections, softgelatine capsules, and ethical based products; and a range of disinfectants, such as hand wash, hand sanitizer, and antimicrobial gels.

Business Segments

1. Pharmaceuticals-100%

Kabra Drugs Ltd. vs Peers — Pharmaceuticals

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Abbott India Ltd.₹56,531 Cr36.334.46%₹1,814 Cr-8.1%
Emcure Pharmaceuticals Ltd₹42,344 Cr47.919.57%₹2,820 Cr+73.3%
Ajanta Pharma Limited₹41,474 Cr39.425.39%₹1,794 Cr+27.8%
Piramal Pharma Ltd₹32,600 Crn/m-4.00%₹2,617 Cr+22.8%
RUBICON RESEARCH LIMITED₹28,526 Cr112.319.14%₹576 Cr+162.7%
Caplin Point Laboratories Ltdte₹18,155 Cr28.319.94%₹630 Cr+23.6%
Pfizer Ltd.₹17,811 Cr24.517.16%₹727 Cr-24.2%
Eris Lifesciences Ltd₹17,691 Cr28.318.07%₹892 Cr-17.5%
Kabra Drugs Ltd.₹49 Cr9.918.28%₹46 Cr+6.6%

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

What is the current share price of Kabra Drugs Ltd.?

Kabra Drugs Ltd. is trading at ₹20.50, with a market capitalisation of ₹49 Cr.

Which sector does Kabra Drugs Ltd. belong to?

Kabra Drugs Ltd. operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Biotechnology and Life Sciences > Pharmaceuticals).

What are the key financial ratios of Kabra Drugs Ltd.?

Kabra Drugs Ltd. has a P/E of 9.9 and a return on equity of 18.28%.

What is the stock symbol of Kabra Drugs Ltd.?

Kabra Drugs Ltd. is listed on the BSE under the scrip code 524322.

How has Kabra Drugs Ltd.'s share price moved over the past year?

Kabra Drugs Ltd.'s share price is up 6.6% over one year and down 14.6% over three months. Its 52-week range is ₹15.25 to ₹35.52.

What were Kabra Drugs Ltd.'s latest quarterly results?

In Q1 FY27, Kabra Drugs Ltd. reported revenue of ₹46 Cr and net profit of ₹2 Cr, with basic EPS of ₹0.9 (standalone, parsed from the company's exchange filing).

How have Kabra Drugs Ltd.'s revenue and profit changed over the past year?

Kabra Drugs Ltd. reported revenue of ₹46 Cr in Q1 FY27, up 546.4% from ₹7 Cr in Q1 FY26 and up 30.5% from ₹35 Cr in Q4 FY26.

What is the promoter holding in Kabra Drugs Ltd.?

Promoters held 60.49% of Kabra Drugs Ltd.'s shares as of Mar 2026, against 60.24% in Mar 2025 (+0.25 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.